[The effect of prophylactic administration of pentoxifylline (trental) on development of a neuropathic pain syndrome and microcirculatory disorders caused by it].
Gorizontova
M P
MP
Mironova
I V
IV
D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects; D015550:Cell Degranulation / Q000187:drug effects; D018056:Hemorheology; D008297:Male; D008407:Mast Cells / Q000166:cytology / Q000187:drug effects; D008833:Microcirculation / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000503:physiopathology; D010146:Pain / Q000517:prevention & control*; D010431:Pentoxifylline / Q000494:pharmacology / Q000627:therapeutic use*; D010523:Peripheral Nervous System Diseases / Q000517:prevention & control*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D010431:Pentoxifylline
Vliianie profilakticheskogo vvedeniia pentoksifillina (trentala) na razvitie neĭropaticheskogo bolevogo sindroma i vyzvannye im narusheniia mikrotsirkuliatsii.